Citigroup »

Bioline Rx shares owned by Citigroup

Quarter-by-quarter ownership of Bioline Rx (BLRX) shares owned by Citigroup from 13F filings

Historical chart of Citigroup investment in Bioline Rx

Tip: Access up to 7 years of quarterly data

All positions including Bioline Rx held by Citigroup consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bioline Rx by Citigroup

Quarter filed Position value Share count Share price at filing
2026-03-31 $4.0k 1.7k 2.31

More positions owned by Citigroup

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Tr Russell 2000 Etf (IWM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
Meta Platforms Cl A (META)
Spdr Gold Tr Gold Shs (GLD)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Bank of America Corporation (BAC)

View all positions for Citigroup

Top funds holding Bioline Rx

Rhumbline Advisers
Bnp Paribas Arbitrage, Snc
Wells Fargo & Company
Citigroup
UBS Group
Nemes Rush Group
Goss Wealth Management
Morgan Stanley
Advisor Group Holdings
Rockefeller Capital Management
Danske Bank A/s
Banque Cantonale Vaudoise

View all funds holding Bioline Rx